Committees

Innovation and Science Australia undertakes some of its responsibilities by utilising a committee structure.

The following committees are currently in place:

Expand / collapse all sections

R&D Incentives Committee

The Research & Development (R&D) Incentives Committee is responsible for providing advice to Innovation and Science Australia about the operations of the R&D Tax Concession Program for income years commencing before 1 July 2011 and the R&D Tax Incentive for income years commencing on or after 1 July 2011.

Dr Marlene Kanga AM - Chair

Portrait of Dr Marlene Kanga

State/Territory

New South Wales

Current position

Chair, Department of Industry innovation and Science, R&D Incentives Committee
Director, iOmniscient Pty. Ltd.
Director, Sydney Water Corporation
Director: Hearing CRC
Director: Asialink.

Expertise/qualifications

Marlene is an experienced company director and a Fellow of the Australian Institute of Company Directors and the Academy of Technology and Engineering. She has degrees in chemical engineering and has a PhD in Finance from Macquarie University.

She has been a champion for innovation, especially in the engineering sector through her leadership roles as a National President of Engineers Australia and as President Elect of the World Federation of Engineering Organisations. She is a director of a company that has commercialised Australian research to develop a platform for intelligent video analytics technologies.

Ms Kathryn Adams

Portrait photograph of Ms Kathryn Adams

State/Territory

Queensland

Current position

Non-Executive Director.

Expertise/qualifications

Ms Kathryn Adams has a strong background in law, R&D investment and corporate governance. She is a non-executive director on six boards in the food and agriculture industry and an Adjunct Research Fellow with the Australian Centre for Intellectual Property in Agriculture (ACIPA). Ms Adams has extensive experience in research and development, innovation, investment and government. She has held senior executive positions in government agencies and business enterprises, including as CEO of two Research and Development Corporations (after beginning her professional career as a bacteriologist).

Ms Adams’ past position include being a research scientist with the former NSW Department of Agriculture, industry liaison officer with CSIRO Food Research, Director of Qld Horticulture Institute, inaugural CEO of Forest and Wood Products R&D Corporation (RDC) and Energy RDC, Deputy Director of the National Standards Commission, inaugural Registrar of Plant Breeder’s Rights, an Executive Director with Queensland Environmental Protection Agency and Senior Research Fellow with Australian Centre for intellectual Property in Agriculture at Griffith University. She has also been a practicing lawyer.

Ms Adams’ non-executive directorships have included Food Science Australia, Plant Health Australia, Safe Food Production Queensland, Forestry South Australia, R&D Corporations and Co-operative Research Centres. She is also the Plant Breeder’s Rights quality reviewer with IP Australia.

Ms Adams is currently serving as a member of Innovation Australia’s R&D Incentives Committee. She is also an Independent non-executive Director on the Boards of Pork CRC Ltd, Dairy Futures CRC Ltd, PBIP Ltd, Agriculture Victoria Services Pty Ltd and D2D CRC Ltd. She is a Board Member of the Cotton Research and Development Corporation (CRDC).

Ms Adams holds a Bachelor of Science in Agriculture as well as Masters in Law, Business and Environmental Studies. She also has a graduate diploma in Legal practices and Professional Certificates in Arbitration and Mediation. She is a Fellow of the Australian Institute of Company Directors.

Ms Julie Phillips

Portrait photograph of Ms Julie Phillips

State/Territory

New South Wales

Current position

Chief Executive Officer, BioDiem
Managing Director, Opal Biosciences Ltd.

Expertise/qualifications

Ms Julie Phillips is Chief Executive Officer and a director of BioDiem Ltd, a Melbourne-based biotechnology company, and Managing Director of BioDiem’s subsidiary, Opal Biosciences Ltd. She has a strong background in the biotech and pharmaceutical industry, having had previous executive director roles of start-up and ASX-listed Australian companies operating in the life sciences sector. Her technical grounding in clinical trials, regulatory affairs and pharmacoeconomic assessment/pricing of therapeutics was gained in multinational pharmaceutical companies where she had responsibility for market entry of new products in Australia and New Zealand.

Ms Phillips is the Chair of AusBiotech Ltd, the peak biotechnology industry association in Australia. She is also a Member of Innovation and Science Australia’s R&D Incentives Committee.

Ms Phillips has a Bachelor of Pharmacology, Master of Science and a Master of Business Administration.

Mr Stevan Green

Portrait photograph of Mr Stevan Green

State/Territory

Western Australia

Current position

Managing Director, Australian Terminal Operations Management Pty Ltd
Executive Consultant and Principal, GreenEng Consulting.

Expertise/qualifications

Mr Stevan Green is the Managing Director of Australian Terminal Operations Management Pty Ltd (ATOM), a joint venture between BP Australia and UGL, which operates a portfolio of fuel terminals across Australia. ATOM is responsible for the safe and efficient receipt, storage and delivery of over 5 billion litres of fuel annually and aims to be the premier fuels terminal operator in Australia.

Mr Green is an Executive Consultant and Principal of GreenEng Consulting, a consulting service to assist project developers, operators and regulators, in project development, management and operation. GreenEng prides itself on finding practical solutions to difficult problems, by identifying all technical and non-technical risks, to deliver commercially robust outcomes. Stevan specifically consults in the areas of:

  • Risk management
  • Sustainable Development
  • Project Management
  • Practical application of state-of-the-art technologies

From 2010 to 2013, Mr Stevan Green was the Managing Director of SUSOP Pty Ltd, an organisation specialising in risk management and implementing sustainable development principals to improve business, environmental and societal outcomes.

Mr Green was the CEO of the Centre for Sustainable Resource Processing for its seven year funding period from 2003 to 2010, in which the Centre developed technological solutions for the minerals processing industry to help reduce ecological impact. He also served as a Board Director of the Geopolymer Foundation for two years.

Mr Green has gained a wealth of experience from his 30 years in management and engineering roles, both in Australia and internationally. He has worked with BHP Billiton, Shell, Qenos, the Government of Mozambique and others in oil and gas, mining, chemicals and food processing.

Mr Green is a Chartered Professional Engineer with an Honours Degree in Mechanical Engineering from the University of Western Australia, and a member of the Australian Institute of Company Directors and the Institute of Engineers, Australia.

Mr Marty Gauvin

Portrait photograph of Mr Marty Gauvin

State/Territory

South Australia

Current position

President and Chief Executive Officer, Virtual Ark.

Expertise/qualifications

Mr Gauvin is an entrepreneur who has established a range of high technology companies. He has founded six businesses to date with the most recent being Virtual Ark, a cloud computing integrator, consultant and managed services provider focussed on advancing capabilities ‘above the cloud’ through rolling out transformational solutions using its own and others IP. Mr Gauvin also founded Tier 5, a developer, owner and manager of modular data centres in secondary cities across Australia. He was key on the development of the Tonsley Park site in Adelaide which is the location of the first Tier 5 data centre. Mr Gauvin is also the Executive Chairman at CloudTech Group Limited.

Previously Mr Gauvin was the Managing Director of Hostworks, a provider of critical application management services to a range of large media and online clients. He has been involved in the assessment and structure of a range of Commonwealth Government innovation programs and was a member of the former Venture Capital Committee of Innovation Australia. He is currently a member of the R&D Incentives Committee of Innovation and Science Australia.

Ms Joanne Mulder

Portrait of Ms Joanne Mulder

State/Territory

Australian Capital Territory

Expertise/qualifications

Ms Joanne Mulder is the General Manager of the Business Equity and Incentives Branch and the Program Delegate for the Research and Development Tax Incentive, which manages the Australian Government’s R&D Tax Incentive.  The largest business research and development program in Australia (with around 15,000 participants).

With extensive experience across the Australian Public Service including senior roles in policy, corporate services and programme management and delivery, Ms Mulder commenced her public service career at the Australian Bureau of Statistics and has held various positions in departments such as the Department of Human Services and the former Department of Climate Change and Energy Efficiency.

Ms Mulder has been with the Department of Industry, Innovation and Science since August 2013 and has a Bachelor of Economics and a Post Graduate Diploma in Business Systems, both from Monash University.

Looking forward to her new role, Ms Mulder joined the R&DTI programme in December 2017 from General Manager of the Entrepreneurs’ Programme.  She had responsibility for the Accelerating Commercialisation, Innovation Connections and the new Incubator Support Initiative, introduced as part of the Australian Government's National Science and Innovation Agenda.

Ms Mulder is an ex-officio on Innovation and Science Australia’s R&D Incentives Committee.


Entrepreneurs' Programme Committee

The Entrepreneurs' Programme Committee operates under delegation from Innovation and Science Australia. The key role for the committee is to provide merit assessments and merit ranking recommendations on applications under the Accelerating Commercialisation programme and the Incubator Support Initiative. These programmes are elements of the Entrepreneurs’ Programme, the Australian Government’s flagship initiative for business competitiveness and productivity at the firm level.

The Committee also provides merit assessments for the Business Research Innovation Initiative which supports Australian businesses to develop innovative solutions that address persistent government challenges.

Mr Chris Farquhar - Chair

Portrait photograph of Mr Chris Farquhar

State/Territory

Western Australia

Current position

Director, Reparo Pty Ltd.

Expertise/qualifications

Mr Chris Farquhar has extensive experience as an entrepreneur, investor, marketer, senior executive and board member at multiple technology and industrial companies, and has domain experience that encompasses security, mobile commerce, telecommunications, industrial automation and sensor networks. He spent an extended period based in the United States, in the Silicon Valley area of California and in Washington DC, and companies he founded have sold products in over 20 countries globally.

Mr Farquhar founded three technology companies that he managed through to acquisitions; two of these were sold to US companies. These included an ISP/Data Centre that was acquired by Amcom Telecommunications and an online vacation property rental marketplace connecting owners and travellers, which was sold to a Californian private equity group. A business he founded in Perth, WiredCity, delivered critical infrastructure management and analytics software to enterprise clients globally and was acquired by US software company OSIsoft. WiredCity’s Industrial Data Centre architecture was a core component of a $300M deal to deliver software to power grids and telecommunications data centres in China.

Since returning to Perth in 2010, Mr Farquhar has been actively facilitating technology investments, structured financing for infrastructure projects in Australia and South-East Asia, and working with an international team to build a technology investment and commercialisation network targeting regional growth opportunities. Mr Farquhar was formerly a Commercialisation Australia Case Manager where he assisted over 30 companies through their commercialisation activities. He is currently the Chair of Innovation and Science Australia’s Entrepreneurs’ Programme Committee.

Mr Farquhar has a Bachelor of Science from the University of Western Australia and completed executive education at Harvard Business School, USA.

Ms Teresa Engelhard

Portrait photograph of Ms Teresa Engelhard

State/Territory

Australian Capital Territory

Current position

Non-Executive Director, RedBubble and Daintree Networks
Board Member, StartupAUS.

Expertise/qualifications

Ms Engelhard has 19 years of technology commercialisation experience as a board member, finance professional, and operating executive with high growth ICT companies in Australia and the US. She is a member of Innovation and Science Australia’s Entrepreneurs’ Programme Committee and has served on over ten boards, including audit and remuneration committees.

Ms Engelhard is currently a Non-Executive Director for RedBubble and Daintree Networks, both with offices in Melbourne and California. She transitioned to a Non-Executive Director path in 2012 following six years as a Managing Partner with Jolimont Capital in Melbourne. At Jolimont Capital, she was responsible for the investment in Auckland–based Next Window which received an AVCAL Chairman’s Award in 2010 for outstanding exit performance.

Prior to moving to Australia, Ms Engelhard served as a C-level executive at both private and public companies in the U.S. and was a venture capitalist with MDV a long-standing Silicon Valley firm. At MDV, she led the investment, revised the business plan, established first customer engagements, and later was recruited as an executive for ONI Systems (ONIS now Ciena). At the time of its IPO ONIS was valued at over $5 billion USD and was MDV’s highest returning investment in its 17-year history. Since moving to Australia in 2006, Ms Engelhard has maintained her Silicon Valley roots by working with Australian and NZ growth companies with U.S. expansion, financing and exit plans. She has thereby travelled to Silicon Valley at least quarterly since residing in Australia.

Ms Engelhard has a B.S. with Honours from the California Institute of Technology (Caltech), an MBA from Stanford University, California.

Dr Carrie Hillyard

Portrait photograph of Dr Carrie Hillyard

State/Territory

Queensland

Current position

Chair, Fitgenes
Chair, FizzioFit Pty Ltd
Deputy Chair, Mater Medical Research Institute.

Expertise/qualifications

Dr Carrie Hillyard is currently Chair of Fitgenes, a company dedicated to preventive healthcare, Chair of FizzioFit Pty Ltd and Deputy Chair of the Mater Medical Research Institute.

Previously, Dr Hillyard was a co-founder of venture fund, CM Capital Investments, a director of several of its investee companies and led its Life Sciences group for over 10 years. She has commercialised products from laboratory bench to market and was an inventor of a number of patented technologies. Her previous experience was in medical and diagnostics research in the UK and Australia.

Dr Hillyard has also mentored entrepreneurs, assisted with commercialisation and licensing and served on a number of government, public and private company boards, including membership of the former Industry Research and Development Board and ANSTO. She is a current member of Innovation and Science Australia’s Entrepreneurs' Programme Committee.

Dr Hillyard has a PhD from London University, elected as a Fellow of the Academy of Technological Sciences and Engineering in 1997 and Fellowship of the Australian Institute of Company Directors in 2012. She was awarded a Centenary medal in 2003, the inaugural Women in Technology Biotechnology Star award in 2006 and the AusBiotech Excellence award in 2008.

Dr James Williams

Portrait photograph of Dr James Williams

State/Territory

Western Australia

Current position

Co-founder and Investment Director of Yuuwa Capital LP; and Director of Yuuwa investee companies AdAlta Limited, PolyActiva Pty Ltd and Nexgen Plants Pty Ltd.

Expertise/qualifications

Dr. James Williams completed his Honors Degree in Biochemistry at Aberdeen University, Doctorate in Medicine at the University of Melbourne, and Masters of Business Administration at the University of Western Australia and has broad experience covering; executive management of public and private companies; establishment, resourcing and financing start-up companies; and hands-on research in molecular and cell biology.

As a co-founder and Investment Director of Yuuwa Capital LP, a $40 million VC fund set up under the Australian Governments Innovation Investment Fund program. Dr. Williams is a Director of Yuuwa investee companies AdAlta Limited (ASX: 1AD), PolyActiva Pty Ltd and Nexgen Plants Pty Ltd, is a member of the “Panel of Experts” for the University of Western Australia’s Pathfinder Fund, a Director of Linear Clinical Research Ltd, an early stage clinical trials unit based in Perth, and a previous member of the Development Grant Review Panel for the National Health and Medical Research Council (NHMRC).

Dr. Williams has been CEO of private and listed medical device companies Argus Biomedical Pty Ltd and  Resonance Health Ltd (spin-out companies from the Lions Eye Institute and UWA respectively), and in both, oversaw regulatory approvals and market launch of first products. He is the former CEO, and remains Chairman of ASX-listed, clinical stage, GPCR drug discovery company Dimerix Limited. In 2003, Dr. Williams conceived the business concept and co-invented the technology behind UWA spin-out iCeutica, holding various Executive and  non-Executive with iCeutica until the company was sold in April 2011 for ten times return on investment at the time of first financing. iCeutica subsequently secured FDA approvals for three drugs developed using its novel delivery technology.

Prior to becoming involved in technology commercialistion, Dr. Williams was Senior Research Officer at the Western Australian Institute for Medical Research where he researched the molecular and cellular biology of cancer. He has numerous publications in leading international journals and is named as inventor on patents covering a range of disciplines that are being prosecuted as part of Australian and US companies’ technology portfolios.

Mr Anthony Surtees

Portrait photograph of Mr Tony Surtees

State/Territory

New South Wales

Current position

Co-Founder, Zeetings.

Expertise/qualifications

Mr Tony Surtees is currently Co-founder of Zeetings, Advisor and Investor for Voicebyte and member of Innovation and Science Australia Entrepreneurs’ Programme Committee. Mr Surtees is a marketer, serial entrepreneur and hands-on board member whose specialties include real time bidding, programmatic buying, electronic and mobile commerce, online retailing, strategy and marketing in mass market consumer, B2C and B2B services.

Mr Surtees is a former Vice President and General Manager of Yahoo!'s Commerce group at their California headquarters, responsible for 14 business units generating over US$2.5B in gross sales. He was previously Chairman of Independent Advisory Group for Australia Post's Postzone, External Advisor for the Victorian Innovation Strategy & Parliamentary Secretary to the Premier of Victoria, and delegate to the 2020 Summit. He was also founder and CEO of iPrime, the digital arm for the Prime Television Group, developing technology and content for media businesses.

Mr Surtees has been the founder and director of private and public companies, a mentor to start-ups, and the past NSW State President of the Australian Marketing Institute. He was Chief Operating Officer of Brandscreen, and a Global Advisory Board Member of Advance, Australia's international network of business professionals, a public-private partnership with a community that spans over 90 countries.

Mr Surtees was nominated by AlwaysOn in the United States as a global digital leader. His reputation as a leading authority on e-commerce, online retail and mobile commerce is well-earned, with best-selling author and entrepreneur Seth Godin describing him as 'one of the most brilliant marketers on the scene today'.

Mr Surtees holds a Bachelor of Commerce from UNSW and a Master of Science from Stanford University.

Mr Steve Telburn

Portrait photograph of Mr Steve Telburn

State/Territory

Queensland

Current position

Managing Director, Secret Source Intellectual Property Ventures.

Expertise/qualifications

Mr Telburn is the Managing Director of Secret Sauce Intellectual Property Ventures, a technology commercialisation and startup advisory firm. He has been the CEO and/or co-founder of five IT startups, taking them from the R&D labs, establishing the business model, securing the first customers, raising venture capital and building management teams. He has personally raised over $10M of venture capital from five different Australian venture capital funds and many angel investors.

Mr Telburn established and ran Offspring Ventures, a successful venture accelerator and technology commercialisation company, owned by an ASX-listed company. He led ten investments across IT&T, engineering and life sciences, including Inference Communications, Dimerix Biosciences (acquired by Sun BioMedical) and iCeutica (acquired by Iroko Pharmaceuticals). He also led the licensing or sale of a portfolio of over 75 patent families acquired from the CSIRO and other public and private research institutions.

In various capacities Steve has played a hands-on role in the creation, strategic planning, turn-around and exit of over 150 technology ventures across the IT&T, life-sciences and engineering sectors. He was a member of the IT&T Committee for Innovation Australia (Commercial Ready Program), the Innovation Grants Committee and a Case Manager with Commercialisation Australia. Mr Telburn is currently a member of Innovation and Science Australia’s Entrepreneurs’ Programme Committee.

Mr Telburn holds a Bachelor of Science and a Masters of Business Administration.


CRC Advisory Committee

The Cooperative Research Centres (CRC) Advisory Committee was established to implement the recommendations of the CRC review - Growth through Innovation and Collaboration: A review of the Cooperative Research Centres Programme Report. The committee’s ongoing role is to provide advice and recommendations on applications for funding; the ongoing progress and performance of individual CRCs; the operation of the CRC Programme.

Mr Philip Marcus Clark AM - Chair

Portrait photograph of Mr Philip Marcus Clark AM

State/Territory

New South Wales

Current position

Director.

Expertise/qualifications

Mr Philip Marcus Clark AM is a member of the JP Morgan Advisory Council. He was Managing Partner and CEO of Minter Ellison. Prior to joining Minter Ellison, Mr Clark was Director and Head of Corporate with ABN Amro Australia and prior to that he was Managing Partner of Mallesons Stephen Jaques. Earlier in his career he worked with a Pratt Industries subsidiary and with Shell Australia.

Mr Clark has extensive experience, as an executive and as a board member, in professional services, investment banking, property and real estate and university and research infrastructure 

Mr Clark serves on a number of boards and advisory boards. His current appointments include: Chair of Cooperative Research Centres (CRC) Advisory Committee; Chair of Shopping Centres Australasia Property Group(ASX code SCP); Director of Ingenia Communities Group (ASX code INA); Chair of M&K Lawyers Holdings Ltd; Chair of NSW Skills Board; Trustee of Royal Botanic Gardens and Domain Trust; Chair of Trustees of NSW Public Purpose Find; Chair of University of Wollongong Early Start Advisory Board; Chair of ATN Universities Research Industry Advisory Board.

Mr Clark has Bachelor degree in Arts and Law from Sydney University and an MBA from Columbia University. He was appointed as a Member in the General Division of the Order of Australia in 2007 for his contribution to the development of national law firms and encouraging corporate involvement in community programs.

Dr Michele Allan

Portrait photograph of Dr Michele Allan

State/Territory

Victoria

Current position

Chancellor, Charles Sturt University.

Expertise/qualifications

Dr Michele Allan has strong leadership experience across many facets of the food industry including a CEO/MD position in a publicly listed food company. Dr Allan was appointed as Chancellor of Charles Sturt University in December 2014. Her areas of expertise include governance, leadership, strategy, agricultural systems innovation, organisational strategy, risk and insurance leadership, food safety systems implementation, food packaging innovation and IP commercialisation.

Dr Allan has held senior executive positions with Amcor Limited, Bonlac Foods, and Bioinformatics Centre of Excellence Tasmania, Kraft Foods and ICI. Until September 2008, Dr Allan was Chief Executive Officer and Managing Director of Patties Foods Limited a manufacturer and marketer of frozen food.

Dr Allan currently holds board positions at Meat and Livestock Australia (Chair Board), Apple and Pear Australia Limited (Non-Executive Director), Innovation and Science Australia (Member), Food and Agribusiness Growth Centre, and Grain Growers. Dr Allan has previously held board positions in both the private and public sectors.

Dr Allan has a Bachelor of Applied Science from University of Technology Sydney, Master of Management of Technology from Melbourne University, Master Commercial Law Deakin University and Doctorate from RMIT. She is a graduate and Fellow of the Australian Institute of Company Directors,  a professional member of Australian Institute of Food, Science and Technology and a Fellow of Australian Academy of Technology and Engineering.

Professor Ian Chubb AC

Portrait photograph of Professor Ian Chubb AC

State/Territory

Australian Capital Territory

Expertise/qualifications

Professor Ian Chubb is the former Chief Scientist of Australia.

Prior to his appointment as Australia's Chief Scientist, Professor Chubb was Vice-Chancellor of the Australian National University. He was Vice-Chancellor of Flinders University of South Australia for six years and the Senior Deputy Vice-Chancellor of Monash University for two years.

Professor Chubb was the Deputy Vice-Chancellor of the University of Wollongong and an Honorary Professor of Biology. He was Lecturer, Senior Lecturer and Associate Professor in the School of Medicine of Flinders University. Before that he was at Oxford University as a Wellcome Foundation Scholar, a Junior Research Fellow of St John’s College, and a Royal Society Research Fellow.

Professor Chubb’s research focused on the neurosciences and was supported by the National Health and Medical Research Council, the Australian Research Grants Scheme and by various Foundations.

Professor Chubb has been awarded 5 honorary doctorates: a DSc from Flinders University, DUniv from the Australian National University, a DLitt from Charles Darwin University, a LLD from Monash University and a DUniv from the University of the Sunshine Coast in 2014. He was the Australian Capital Territory’s Australian of the Year in 2011.

Professor Chubb was appointed as an Officer in the Order of Australia in 1999 (AO) and in 2006 he was appointed as a Companion of the Order (AC).

Professor Christobel Saunders

Portrait photograph of Professor Christobel Saunders

State/Territory

Western Australia

Current position

Professor of Surgical Oncology, academic surgeon, cancer researcher and teacher of surgery at the School of Surgery, the University of Western Australia.

Expertise/qualifications

Professor Saunders MBBS Lond, FRCS England FRACS, is internationally recognised as one of Australia’s most prominent research-orientated cancer surgeons. She has contributed to many clinical aspects of breast cancer research including clinical trials of new treatments, psychosocial and health services research and is active in several areas of surgical oncology cancer research. Professor Saunders is past President of the Cancer Council WA (2009-2013) and past founding Council member of Cancer Australia. She has been closely involved in strategic planning and management of cancer research and services nationally with Cancer Australia, as Board Member of Breast Cancer Network Australia and the ANZBCTG, and previous member of the Lead Clinicians Group; as well as author of the WA health Cancer Services Framework, inaugural Director of the Sate-wide Cancer and Palliative Care Network and Chair of the Cancer Services Taskforce.

Professor Saunders has an exceptional funding track record as an investigator, having attracted a career total of over $27 million in over 50 competitive research grants (since 2001). She has published over 150 scientific papers in refereed journals, (90 in the past 5 years), three books and 18 book chapters. Translation of her research into improvements in patient care has been facilitated through her roles as Executive member of a number of groups within the Royal Australasian College of Surgeons, in the development of numerous guidelines for both patients and clinicians, and as a Fellow of the Academy of Health and Medical Sciences. Based on Professor Saunders’ research and advocacy, there have been a number of advances in the management of breast cancer in Australia. These include the use of breast MRI to screen high risk women (and the successful introduction of a Medicare Item number for this) coming directly from her leadership of a national advocacy group; and a successful application to list intraoperative radiotherapy as a new item on the Medicare Benefit Schedule in 2015.

Ms Kylie Sproston

Portrait photograph of Ms Kylie Sproston

State/Territory

South Australia

Current position

Chief Executive Officer, Bellberry Ltd.

Expertise/qualifications

Ms Kylie Sproston is CEO of Bellberry, a not for profit organisation providing streamlined scientific and ethical review of Human Research projects across Australia.  A Chartered Engineer, Ms Sproston has expertise across the full pharmaceutical product lifecycle, and has held key positions in both technical and management disciplines in the global Pharmaceutical and Biotech industries. Ms Sproston previously led and managed the Australasian operations of the global group BTG PLC (a specialist healthcare company based in London, UK), as General Manager and Company Director.  Prior to that, she undertook a number of roles within various functions in the Global company AstraZeneca.

Ms Sproston received a MEng (Hons) in Mechanical Engineering from Loughborough University (UK) and an MSc in Pharmaceutical Engineering Advanced Training from University of Manchester (UK). She is a Graduate of the AICD Company Directors Course.

Mr Doug Stuart

Portrait photograph of Douglas (Doug) Joseph Stuart

State/Territory

New South Wales

Current position

Co-Founder & Chief Marketing Officer, Instaclustr Pty Ltd and Director, Enabled Employment Pty Ltd.

Expertise/qualifications

Mr Douglas Stuart is an Australian executive and entrepreneur in the cyber security, cloud computing and critical infrastructure industries. He has extensive experience building technology companies, capabilities and quality assured programs, teams and services.

Mr Stuart is a co-founder, investor and the Chief Marketing Officer at Instaclustr, a company providing managed solutions, support and consulting services for open source big data technologies.  Instaclustr is backed by Bailador, ANU Connect Ventures and Our Innovation Fund, leading Australian venture capital firms.

Prior to Instaclustr, Mr Stuart was a co-founder of Stratsec, a world-class, highly awarded and recognised cyber security consulting, testing and research firm, which was acquired by BAE Systems in 2011.  Stratsec was awarded Telstra Business of the Year in 2010. Mr Stuart has also been recognised as a leading entrepreneur in the industry through the Ernst & Young Entrepreneur of the Year Program in 2010.

Mr Stuart obtained an Associate Diploma of Electronics Engineering from Canberra Institute of Technology in 1991 and a Master of Business Administration (Information Technology) from Charles Sturt University in 2013.

Ms Sue Weston PSM

Portrait photograph of Ms Sue Weston

State/Territory

Australian Capital Territory

Current position

Deputy Secretary, Department of Industry, Innovation and Science.

Expertise/qualifications

Ms Sue Weston is the Deputy Secretary, currently responsible for the department’s science groups, of which include the Science and Commercialisation division, Questacon (the National Science and Technology Centre), the National Measurement Institute and the Australian Astronomical Observatory.  Sue also has responsibility for the department’s budget, corporate division; and is the department’s disability champion.

Ms Weston has previously provided policy advice and support to portfolio Ministers on issues relevant to industry and small business in Australia. Her roles have included working with other Australian Government departments and agencies to assist them to better assess the impact policies may have on small business.

Ms Weston has been involved in a number of corporate roles in the Department of Innovation including time as Deputy Chair of the Audit Committee and Chair of the Financial Statement Sub-committee. In recent years Ms Weston has had experience in managing Machinery of Government changes.

Prior to her appointment in her current Department, Ms Weston had an extensive career in the Australian Taxation Office, working in a wide range of areas, and in particular on business education and training in relation to the New Tax System reforms.

Ms Weston has a Bachelor of Science degree, a Graduate Diploma in Professional Accounting and is a Fellow of CPA Australia.


Innovation Investment Committee

The role of the Innovation Investment Committee is to assist Innovation and Science Australia administer the suite of venture capital programmes, and provide guidance to the Department throughout the lifecycles of the various programmes. For the venture capital tax concession programmes Venture Capital Limited Partnerships (VCLP), Early Stage Venture Capital Limited Partnerships (ESVCLP) and Pooled Development Funds (PDF), this include decisions on registration, and decisions relating to compliance and interpretation of provisions in the relevant Acts.

Mr Marty Gauvin - Chair

Portrait photograph of Mr Marty Gauvin

State/Territory

South Australia

Current position

President and Chief Executive Officer, Virtual Ark.

Expertise/qualifications

Mr Marty Gauvin is an entrepreneur who has established a range of high technology companies. He has founded six businesses to date with the most recent being Virtual Ark, a cloud computing integrator, consultant and managed services provider focused on advancing capabilities ‘above the cloud’ through rolling out transformational solutions using its own and others’ IP. Mr Gauvin is also the Executive Chairman at CloudTech Group Limited.

Previously Mr Gauvin was the Managing Director of Hostworks, a provider of critical application management services to a range of large media and online clients. Mr Gauvin has been involved in the assessment and structure of a range of Commonwealth Government innovation programs and is currently the Chair of the Innovation Investment Committee of Innovation and Science Australia and a member of the R&D Incentives Committee of Innovation and Science Australia.

Professor Stephen Barkoczy

Portrait photograph of Professor Stephen Barkoczy

State/Territory

Victoria

Current position

Professor, Faculty of Law, Monash University

Expertise/qualifications

Professor Stephen Barkoczy has worked for many years in the Faculty of Law at Monash University and has lectured, researched and practised widely in the areas of taxation, superannuation and venture capital law.

He is also a consultant to the Australian Taxation Office and a member of the International Faculty of the Institute for Austrian and International Tax Law at the Vienna University of Economics and Business, where he lectures in its Master of Laws program in International Tax Law.

Previously, Professor Barkoczy was a consultant with one of Australia’s major law firms for over 12 years. He has also served as Chairman of the Law Institute of Victoria’s Tax and Revenue Committee and Principal Examiner of its Tax Law Specialisation program. Professor Barkoczy has been appointed to various Government advisory panels and was a member of the Venture Capital Committee of Innovation Australia from 2011 to 2014.

Professor Barkoczy is the recipient of numerous teaching awards, including the 2008 Prime Minister's Award for Australian University Teacher of the Year. He is also the author/co-author of many major books dealing with taxation and venture capital law, including Innovation and Venture Capital Law and Policy published by Federation Press in 2016.

Ms Jan Bingley

Portrait photograph of Ms Jan Bingley

State/Territory

New South Wales

Current position

General Manager Business Development, Global CCS Institute.

Expertise/qualifications

Ms Jan Bingley is a senior executive with career in finance and venture capital, with most recent role leading innovation and commercialisation at Australia’s premier research organisation, the CSIRO. She is currently employed by the Global CCS Institute where she is responsible for Business Development and Strategy.

Ms Bingley has global experience in managing and sourcing innovation risk capital with strong networks in Venture Capital, Private Equity and Strategic Venture. She has a proven track record in forming and growing innovative start-up companies based on deep science and intellectual property – gained in both private and government sector. Ms Bingley has been directly involved with over 25 spin-out companies from CSIRO.

Ms Bingley has been a board member of a number of CSIRO spin-out companies, was a board member of Commercialisation Australia, and is on the Executive Committee of Knowledge Commercialisation Australasia. She is also on the Investment Committee for TankStream Ventures – a Sydney based seed investing firm and is on the Board of the Alertness CRC.

Ms Bingley is a member of the Innovation Investment Committee of Innovation and Science Australia

Ms Amanda Heyworth

Portrait photograph of Ms Amanda Heyworth

State/Territory

South Australia

Current position

Non-Executive Director, Ingenia Communities Group Ltd.

Expertise/qualifications

Ms Amanda Heyworth serves as a non-executive director of Ingenia Communities Group Ltd (ASX:INA), ITEK Ventures Pty Ltd, Executive Leadership Connection Pty Ltd and as a board adviser to a number of private companies and not for profits.  She is an adjunct faculty member of the Australian Graduate School of Management leading a subject on product and service innovation.

Prior to becoming a non-executive director, Ms Heyworth served as CEO of a venture capital fund and co-founded a software company.  In these roles, she has been involved in numerous product launches and M&A transactions.  Early in her career, Ms Heyworth worked as investment banker and a Federal Treasury economist.

Ms Heyworth is a member of the Innovation Investment Committee of Innovation and Science Australia.

Ms Jennifer Kay

Portrait of Ms Jennifer Kay

State/Territory

Australian Capital Territory

Current position

General Manager, Business Management Branch.

Expertise/qualifications

Ms Jennifer Kay joined the Department of Industry, Innovation and Science in March 2017 as General Manager, Business Management Branch. In this role she is responsible for delivery of some of the Departments flagship programmes including elements of the Entrepreneurs’ Programme, the range of Venture Capital programmes and the Business Research and Innovation Initiative. Ms Kay also has oversight of the secretariat functions for the Innovation and Science Australia’s (ISA) Committees, ensuring the Department has effective governance in place for its key programs.

Prior to this Ms Kay has spent the majority of her career in the Department of Social Services working on a range of policy and program areas including whole-of-portfolio program policy and design, not-for-profit sector policy and engagement, charity regulation, oversight of Ministerial and Executive Services, establishment of child and family programs in remote communities in the Northern Territory and establishment of the Community Grants Hub.

Ms Jennifer Kay is an ex-officio member of ISA’s Innovation Investment Committee.


Biomedical Translation Fund Committee

The role of the Biomedical Translation Fund Committee is to assist Innovation and Science Australia administer the Biomedical Translation Fund programme and provide guidance to the department throughout the lifecycle of the programme.

Mr Peter Wills AC - Chair

Portrait of Mr Peter Wills AC

State/Territory

New South Wales

Current position

Director – Wills Advisory
Chair – Bio Deputy Chair – Research Australia.

Expertise/qualifications

In June 1996, Mr Wills was appointed as a Member in the General Division of the Order of Australia for service to the community.  In June 2001, he was appointed as a Companion in the General Division of the Order of Australia for service to social and economic advancement through the development of public policy in relation to biomedical research and biotechnology.

In 1996, Mr Wills chaired the committee, formed by the Minister for Health and Aged Care, Dr Michael Wooldridge, which took on the task of assessing Australia's health and medical research.  The Wills report was released in 1999 and was instrumental in bringing medical research to the attention of the media and increasing funding for Australian science.  This report: The Virtuous Cycle: Working Together for Health and Medical Research lead directly to the formation of Research Australia and Mr Wills remains an active and important member of the Research Australia board, of which he is Deputy Chair.

Mr Wills was also appointed a member of The Biotechnology Consultative Group formed in 1999, to advise Biotechnology Australia and the Commonwealth Biotechnology’s Ministerial Council on the development of the National Biotechnology Strategy.  In 2002 Mr Wills retired as Chairman of the Australian Research Council.  He has been Chairman of the Garvan Institute of Medical Research, Chairman of the Australian Research Council and also contributed to the National Biotechnology Strategy.  In 2001 Mr Wills served on the committee, Chaired by Chief Scientist Dr Robin Batterham, which lead to the Federal Government’s Innovation Statement.

In 2011/12, Mr Wills chaired the NSW Health & Medical Research Review for the NSW State Government.  The Review assessed the current performance of health and medical research in NSW, made recommendations on how the sector can be improved, better coordinated and leveraged; and proposed ways in which the NSW health needs, clinical trials and commercialisation capacity can be better supported or expanded.  The majority of the recommendations were accepted by the NSW Government.

Mr Wills and has a background in architecture, business and local government prior to his involvement in the health and medical research sector.

Dr Leanna Read

Portrait of Dr Leanna Read

State/Territory

South Australia

Current position

Chief Scientist for South Australia.

Expertise/qualifications

Dr Leanna Read is the fourth Chief Scientist for South Australia and a renowned biotechnology expert. Dr Read brings a wealth of executive, board and investment experience in technology-based businesses.

In addition to her current roles, Dr Read has led a number of successful research and commercial ventures, including the Child Health Research Institute and the Cooperative Research Centre for Tissue Growth and Repair. Dr Read was the founding Managing Director and CEO of Adelaide biotechnology company, TGR BioSciences from 2001 to 2012.

Dr Read is a Member of the Biomedical Translation Fund Committee and the Economic Development Board of South Australia. Board member, Biosensis Pty Ltd and Chair, Cooperative Research Centre for Cell Therapy Manufacturing and Carina Biotech Pty Ltd.

Dr Read’s contributions to science and industry have been recognised by a number of prestigious awards, including fellowship of the Australian Academy of Technological Sciences and Engineering.

Ms Fiona Pak-Poy

Portrait of Ms Fiona Pak-Poy

State/Territory

New South Wales

Current position

Independent Non-Executive Director at MYOB Group Ltd; iSentia Group Ltd. 

Expertise/qualifications

Ms Fiona Pak-Poy is on the Board of Directors at MYOB Group Ltd, iSentia Group Ltd, the Sydney School of Entrepreneurship and the Securities Institute Research Centre of Asia Pacific (SIRCA).

Ms Pak-Poy was previously employed as a General Partner of Innovation Capital, an Australian venture capital fund and as such was Chair or Board member of a number of technology start up companies, including Opto Global Pty Ltd, Audinate Pty Ltd and Call Journey Pty Ltd. Previously Ms. Pak-Poy was a consultant with The Boston Consulting Group. Ms Pak-Poy is a former Innovation Australia Board member and former member of a number of its committees such as COMET, the inaugural board of Commercialisation Australia, the Clean Technology Fund and the Industry Innovation Follow on Fund.

Ms Pak-Poy has a Bachelors degree in Civil Engineering from the University of Adelaide and an MBA from Harvard Business School. 

Professor Melissa Little

Portrait of Professor Melissa Little

State/Territory

Victoria

Current position

Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.

Expertise/qualifications

Professor Melissa Little heads the Kidney Research Laboratory at the Murdoch Childrens Research Institute, The Royal Children's Hospital in Melbourne.

An alumnus of The University of Queensland, Brisbane, Australia, Professor Little worked for more than 20 years at the Institute for Molecular Bioscience, where her research focused on the molecular basis of kidney development, renal disease and repair.  Professor Little is internationally recognised both for her work on the systems biology of kidney development and also for her pioneering studies into potential regenerative therapies in the kidney.

This work has encompassed the characterisation of adult stem cells in the kidney as well as analyses of the embryonic progenitor population.  Professor Little’s work on the developing kidney has driven studies into the recreation of nephron stem cell populations via transcriptional reprogramming and directed differentiation of pluripotent stem cells. As a result, her research now focuses on the generation of mini-kidneys from patient stem cells for use in drug screening and disease modelling.

Professor Little's work has been recognised by many awards, including a Royal Society Endeavour Fellowship at the Medical Research Council Human Genetics Unit, Edinburgh, Scotland.  Professor Little has also received the GlaxoSmithKline Award for Research Excellence (2005), the Australian Academy of Sciences Gottschalk Medal in Medical Sciences (2004), an Eisenhower Fellowship (2006), Boorhaave Professorship, Leiden University (2015) and a Eureka Prize (2016). She is a Fellow of the Australian Academy of Science and a Fellow of the Australian Academy of Health and Medical Science.

A graduate of the Australian Institute of Company Directors, she founded Nephrogenix Pty Ltd and was on the board of this company.  From 2007 2008, she served as the Chief Scientific Officer at the Australian Stem Cell Centre.  Professor Little is currently the President of the Australasian Society for Stem Cell Research and a member of Stem Cells Australia and is on the editorial board of the Journal of the American Society for Nephrology, Kidney International, Development and Developmental Biology. 

Dr Christopher Roberts

Portrait photograph of Dr Chris Roberts 

State/Territory

New South Wales

Current position

PluS Alliance Professor (UNSW Sydney, King’s College London and Arizona State University).

Expertise/qualifications

Dr Chris Roberts has 40 years of experience in international medical device businesses covering medical disciplines such as nephrology, orthopedics, and cardiology, respiratory, sleep medicine and otolaryngology. These businesses are characterised as being global in nature and driven by innovation.

Dr Roberts was the CEO/President of Cochlear Limited, a global market leader in implantable devices for the hearing impaired, from February 2004 to August 2015.

Dr Roberts was a non-executive director of ResMed Inc from 2004 to 2017, having served as Executive Vice-President ResMed Inc. from 1992 until he became CEO of Cochlear Limited (2004).  Dr Roberts is a member of numerous boards, committees and councils, and has been awarded honorary Doctor of Science degrees from both Macquarie University and the University of NSW.  Dr Roberts is also a Fellow of the Academy of Technological Sciences and Engineering (FTSE), Fellow of the Australian Institute of Company Directors (FAICD) and Fellow of the Institution of Engineers Australia (FIEAust).

Dr Roberts holds a PhD in Biomedical Engineering and a Bachelor of Chemical Engineering (Hons) from UNSW, as well as an MBA from Macquarie University.

Dr Deborah Rathjen

Portrait of Dr Deborah Rathjen

State/Territory

New South Wales

Current position

Managing Director of Bionomics Corporation.

Expertise/qualifications

Dr Deborah Rathjen is significant in the sense that she started off with a virtual company and has turned Bionomics into a notable Biotechnology/Biomedical firm with a $200 million market capitalisation.

Dr Rathjen’s efforts in the field of biology have been far reaching and impacting.  Dr Rathjen’s role in the development of cancer treating drugs and other medications is a large contribution to Bionomics' current success in the biotechnology market.  Numerous articles have been written about her recent discoveries in cancer treatment and other medical conditions.  In recent times she has presided over many contributions to new medical technologies including prostate cancer treatment and anxiety treatment.

Dr Rathjen has also been named as one of the Knowledge Nation 100, a group of visionaries, intellects, founders and game changers seen as the foremost contributors to Australia’s knowledge economy.  Identified by the Office of the Chief Scientist, The Australian newspaper and the Knowledge Society, the Knowledge Nation 100 are described as the people “building the industries and infrastructure that will underwrite Australia’s future prosperity”.

Mr Jeremy Samuel

Portrait of Mr Jeremy Samuel

State/Territory

New South Wales

Current position

Founder and Managing Director of Anacacia Capital.

Expertise/qualifications

Mr Samuel is a Non-Executive Director of Anacacia portfolio company: Yumi's Quality Foods. He was also the former lead director for Anacacia's successful investments into: Appen, Rafferty's Garden, Lomb Scientific and Home Appliances. Mr Samuel chairs Anacacia’s investment committee and is a member of the Growth Funds Stakeholder Committee for the Australian Private Equity and Venture Capital Association (AVCAL).

Mr Samuel is the former Chair of ANZ's private equity management committee and was previously a strategy consultant with Booz Allen (now PwC Strategy&). Mr Samuel holds an MBA from Yale University School of Management and Arts/Law degrees from the University of New South Wales.

Share this Page